Exelixis
EXEL
#1765
Rank
ยฃ8.81 B
Marketcap
ยฃ32.89
Share price
-2.51%
Change (1 day)
21.88%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2025 (TTM): ยฃ0.70 Billion

According to Exelixis's latest financial reports the company's current earnings are ยฃ2.32 Billion. , an increase over its 2024 earnings that were of ยฃ0.50 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2025

Annual earnings

Year Earnings Change
2025 ยฃ0.69 B38.08%
2024 ยฃ0.50 B164.69%
2023 ยฃ0.19 B9.89%
2022 ยฃ0.17 B-20.33%
2021 ยฃ0.21 B124.82%
2020 ยฃ97.19 M-67.14%
2019 ยฃ0.29 B-11.94%
2018 ยฃ0.33 B185.09%
2017 ยฃ0.11 B-325.82%
2016 -ยฃ52.17 Million-58.12%
2015 -ยฃ0.13 Billion-37.61%
2014 -ยฃ0.2 Billion9.75%
2013 -ยฃ0.19 Billion65.96%
2012 -ยฃ0.11 Billion-291.63%
2011 ยฃ57.19 M-195.59%
2010 -ยฃ59.84 Million-42.17%
2009 -ยฃ0.11 Billion-18.98%
2008 -ยฃ0.13 Billion-6.99%
2007 -ยฃ0.14 Billion46.3%
2006 -ยฃ93.86 Million33.25%
2005 -ยฃ70.44 Million-30.92%
2004 -ยฃ0.11 Billion44.29%
2003 -ยฃ70.67 Million12.86%
2002 -ยฃ62.62 Million22.79%
2001 -ยฃ51 Million60.14%
2000 -ยฃ31.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.92 B 3,464.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ7.57 B 982.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.66 B 853.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ5.71 B 718.02%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ16.65 B 2,282.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.92 B 891.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ7.35 B 951.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-ยฃ24.19 Million-103.46%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-ยฃ21.58 Million-103.09%๐Ÿ‡บ๐Ÿ‡ธ USA